Other

Sacklers agree to new $6bn Purdue US settlement over opioids

The Sackler family will pay up to $6 billion to address damage linked to the US opioid crisis under an amended Purdue Pharma bankruptcy plan following an agreement with holdout states, according to a court filing Thursday.

Other

Purdue Pharma owners up opioid settlement offer to $6 bn

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.

HIV & AIDS

Sex with HIV still a crime? Updated laws divide advocates

As Sanjay Johnson describes it, his sexual encounter with James Booth on Oct. 2, 2015, was a one-night stand. But it would bind the men inextricably two years later, when Booth walked into an Arkansas police station and accused ...

Other

US moves to block Purdue Pharma opioid settlement

The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.

Diseases, Conditions, Syndromes

US approves dengue vaccine Dengvaxia

US health authorities have given their approval to dengue vaccine Dengvaxia, the controversial first treatment designed to protect against the deadly mosquito-borne virus.

page 1 from 4